(Q81638302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

A 32-year-old man with relapsing-progressive brainstem symptoms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Helmar C Lehmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Ulrich R Hengge

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Lutz Alswede

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Andreas Saleh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Gloria von Geldern

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Hans Peter Hartung

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Thomas Ruzicka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Bernhard Hemmer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

97-102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Vasculitis of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

1 reference

7 January 2021

Neurologic presentation of Whipple disease: report of 12 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Clinical features and diagnosis of celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Neurologic presentation of celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Ataxia-telangiectasia: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Cerebral white-matter changes suggesting leukodystrophy in ataxia telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Dystonia in ataxia telangiectasia: report of a case with putaminal lesions and decreased striatal [123I]iodobenzamide binding

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Fabry disease: a study of 6 hemizygous men and 5 heterozygous women with emphasis on dermatologic manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Fabry's Disease: Alpha-Galactosidase Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Prevalence of lysosomal storage disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Clinical features of and recent advances in therapy for Fabry disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Stroke in Fabry's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Cerebrovascular complications of Fabry's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Fabry's disease presenting with stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

'Atypical' clinical variants of Anderson-Fabry disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

An Atypical Variant of Fabry's Disease in Men with Left Ventricular Hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Recurrent strokes in a young adult patient with Fabry's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

High incidence of thrombosis in Fabry's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Selective arterial distribution of cerebral hyperperfusion in Fabry disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Enhanced endothelium-dependent vasodilation in Fabry disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Use of gabapentin to reduce chronic neuropathic pain in Fabry disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

Carbamazepine in Fabry's disease: effective analgesia with dose-dependent exacerbation of autonomic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970287-8

7 January 2021

10.1016/S1474-4422(05)70287-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16361027%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference